Funding
← Back to your selection

Angelini Ventures

angeliniventures.com ↗Activity from announced rounds

Activity in this selectionOct 20, 2026 · Sep 21, 2026

Angelini Ventures invests globally in biotechnology and health technology as the venture capital organization of Angelini Industries.

Investment focus

Its investment focus is on technologies that address unmet healthcare needs and improve patient journeys. The firm supports founders with capital, enterprise capabilities and connections across industry, research and investing.

Activity recorded by RoundOS

RoundOS records include Aptadir’s RNA therapeutics, Epicrispr’s epigenetic medicines, MMI’s robotic microsurgery and Handspring’s mental-health services. They show recorded activity across therapeutic development, medical devices and care delivery. The examples are a bounded selection from this database rather than the full Angelini Ventures portfolio.

Sources
Rounds participated in
2
Confirmed lead rounds
0
All roles disclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$45.4M
1 disclosed · full round size, not this investor’s share

By stage

Seed1
Series C+1

By primary sector

Biotech2

By country

Italy1
Switzerland1

Rounds

2 in this selection
Nouscom

Clinical-stage biotech developing neoantigen-based cancer immunotherapies.

€120MSeries D
Participant